230 related articles for article (PubMed ID: 18450412)
1. Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells.
Kameswaran TR; Ramanibai R
Biomed Pharmacother; 2009 Feb; 63(2):146-54. PubMed ID: 18450412
[TBL] [Abstract][Full Text] [Related]
2. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
[TBL] [Abstract][Full Text] [Related]
3. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC
Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155
[TBL] [Abstract][Full Text] [Related]
4. Tetrandrine-induced cell cycle arrest and apoptosis in A549 human lung carcinoma cells.
Lee JH; Kang GH; Kim KC; Kim KM; Park DI; Choi BT; Kang HS; Lee YT; Choi YH
Int J Oncol; 2002 Dec; 21(6):1239-44. PubMed ID: 12429973
[TBL] [Abstract][Full Text] [Related]
5. 5'-nitro-indirubinoxime induces G2/M cell cycle arrest and apoptosis in human KB oral carcinoma cells.
Kim SA; Kim SW; Chang S; Yoon JH; Ahn SG
Cancer Lett; 2009 Feb; 274(1):72-7. PubMed ID: 18926623
[TBL] [Abstract][Full Text] [Related]
6. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells.
Shi J; Shen HM
Biochem Pharmacol; 2008 May; 75(9):1729-42. PubMed ID: 18377873
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells.
Marko D; Schätzle S; Friedel A; Genzlinger A; Zankl H; Meijer L; Eisenbrand G
Br J Cancer; 2001 Jan; 84(2):283-9. PubMed ID: 11161389
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells.
Perabo FG; Landwehrs G; Frössler C; Schmidt DH; Mueller SC
Urol Oncol; 2011; 29(6):815-20. PubMed ID: 19945313
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of novel indirubin derivatives in rat tumor model.
Kim SA; Kim YC; Kim SW; Lee SH; Min JJ; Ahn SG; Yoon JH
Clin Cancer Res; 2007 Jan; 13(1):253-9. PubMed ID: 17200363
[TBL] [Abstract][Full Text] [Related]
11. Enniatin exerts p53-dependent cytostatic and p53-independent cytotoxic activities against human cancer cells.
Dornetshuber R; Heffeter P; Kamyar MR; Peterbauer T; Berger W; Lemmens-Gruber R
Chem Res Toxicol; 2007 Mar; 20(3):465-73. PubMed ID: 17326668
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation.
Koceva-Chyła A; Jedrzejczak M; Skierski J; Kania K; Jóźwiak Z
Apoptosis; 2005 Dec; 10(6):1497-514. PubMed ID: 16215684
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro.
Kim SH; Choi SJ; Kim YC; Kuh HJ
Arch Pharm Res; 2009 Jun; 32(6):915-22. PubMed ID: 19557370
[TBL] [Abstract][Full Text] [Related]
14. 6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.
Xingi E; Smirlis D; Myrianthopoulos V; Magiatis P; Grant KM; Meijer L; Mikros E; Skaltsounis AL; Soteriadou K
Int J Parasitol; 2009 Oct; 39(12):1289-303. PubMed ID: 19445946
[TBL] [Abstract][Full Text] [Related]
15. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND
Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative and pro-apoptotic effect of CPT13, a novel camptothecin analog, on human colon cancer HCT8 cell line.
Wang LM; Li QY; Zu YG; Fu YJ; Chen LY; Lv HY; Yao LP; Jiang SG
Chem Biol Interact; 2008 Nov; 176(2-3):165-72. PubMed ID: 18708040
[TBL] [Abstract][Full Text] [Related]
17. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Ji YB; Zhou JH; Zuo MX; You QD
Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
[TBL] [Abstract][Full Text] [Related]
18. Rhabdoid tumor growth is inhibited by flavopiridol.
Smith ME; Cimica V; Chinni S; Challagulla K; Mani S; Kalpana GV
Clin Cancer Res; 2008 Jan; 14(2):523-32. PubMed ID: 18223228
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by flavonoids from Astragalus complanatus.
Hu YW; Liu CY; Du CM; Zhang J; Wu WQ; Gu ZL
J Ethnopharmacol; 2009 Jun; 123(2):293-301. PubMed ID: 19429375
[TBL] [Abstract][Full Text] [Related]
20. Shikonin-induced apoptosis involves caspase-3 activity in a human bladder cancer cell line (T24).
Yeh CC; Kuo HM; Li TM; Lin JP; Yu FS; Lu HF; Chung JG; Yang JS
In Vivo; 2007; 21(6):1011-9. PubMed ID: 18210748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]